Cronos (CRON) has completed its previously announced acquisition of Dutch cannabis company CanAdelaar for 57.5 million euros ($64.4 million), the company said Thursday.
The base purchase price is in addition to a contingent cash earnout of 0.5 times CanAdelaar's normalized earnings before interest, taxes, depreciation, and amortization in 2026 and 2027, the company said.
CanAdelaar former Chief Executive Christopher Martens has been named general manager of Cronos Netherlands, the company said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments